BÜYÜKAŞIK, Y. 2011. Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.21, no.2 , 4-9.

BÜYÜKAŞIK, Y., (2011). Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.21, no.2, 4-9.

BÜYÜKAŞIK, YAHYA. "Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.21, no.2, 4-9, 2011

BÜYÜKAŞIK, YAHYA. "Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.21, no.2, pp.4-9, 2011

BÜYÜKAŞIK, Y. (2011) . "Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.21, no.2, pp.4-9.

@article{article, author={YAHYA BÜYÜKAŞIK}, title={Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2011, pages={4-9} }